| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.29 | 7e-09 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.28 | 4e-07 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.24 | 5e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.24 | 7e-06 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.07 | 0.2 |